These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27748803)

  • 1. ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
    Xie Q; Su J; Jiao B; Shen L; Ma L; Qu X; Yu C; Jiang X; Xu Y; Sun L
    Int J Oncol; 2016 Dec; 49(6):2507-2519. PubMed ID: 27748803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
    Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
    Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3 cells.
    Xu L; Xie Q; Qi L; Wang C; Xu N; Liu W; Yu Y; Li S; Xu Y
    Oncol Rep; 2018 Mar; 39(3):985-992. PubMed ID: 29286126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation.
    Hou L; Wang R; Wei H; Li S; Liu L; Lu X; Yu H; Liu Z
    Life Sci; 2019 Sep; 232():116561. PubMed ID: 31247208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells.
    Yu Y; Xu L; Qi L; Wang C; Xu N; Liu S; Li S; Tian H; Liu W; Xu Y; Li Z
    Biomed Pharmacother; 2017 Dec; 96():22-29. PubMed ID: 28963947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells.
    Dong D; Dong Y; Fu J; Lu S; Yuan C; Xia M; Sun L
    Life Sci; 2020 Aug; 255():117846. PubMed ID: 32470451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrient Starvation Sensitizes Human Ovarian Cancer SKOV3 Cells to BH3 Mimetic via Modulation of Mitochondrial Dynamics.
    Wang S; Mao Y; Xi S; Wang X; Sun L
    Anat Rec (Hoboken); 2017 Feb; 300(2):326-339. PubMed ID: 27486855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
    Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
    Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics.
    Fan Z; Yu H; Cui N; Kong X; Liu X; Chang Y; Wu Y; Sun L; Wang G
    Exp Cell Res; 2015 Jul; 335(1):68-81. PubMed ID: 25936772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells.
    Li X; Guo Y; Xing Z; Gong T; Yang L; Yang T; Chang B; Wang X; Yu B; Guo R
    Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 39054955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
    Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis.
    Xu Y; Wang C; Su J; Xie Q; Ma L; Zeng L; Yu Y; Liu S; Li S; Li Z; Sun L
    Oncol Rep; 2015 Dec; 34(6):3051-60. PubMed ID: 26398138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin.
    Geserick P; Wang J; Feoktistova M; Leverkus M
    Cell Death Dis; 2014 Sep; 5(9):e1412. PubMed ID: 25210795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-737 sensitizes curcumin-induced anti-melanoma cell activity through facilitating mPTP death pathway.
    Yu T; Chen C; Sun Y; Sun H; Li TH; Meng J; Shi X
    Biochem Biophys Res Commun; 2015 Aug; 464(1):286-91. PubMed ID: 26116776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.
    Kim EY; Jung JY; Kim A; Chang YS; Kim SK
    Neoplasia; 2017 Apr; 19(4):354-363. PubMed ID: 28319809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.
    Lin X; Morgan-Lappe S; Huang X; Li L; Zakula DM; Vernetti LA; Fesik SW; Shen Y
    Oncogene; 2007 Jun; 26(27):3972-9. PubMed ID: 17173063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
    Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance.
    Salm F; Cwiek P; Ghosal A; Lucia Buccarello A; Largey F; Wotzkow C; Höland K; Styp-Rekowska B; Djonov V; Zlobec I; Bodmer N; Gross N; Westermann F; Schäfer SC; Arcaro A
    Oncogene; 2013 Aug; 32(34):3944-53. PubMed ID: 23027129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins.
    Hadjidaniel MD; Reynolds CP
    Mol Cancer Ther; 2010 Dec; 9(12):3164-74. PubMed ID: 21159604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.